Lilly increases manufacturing investment to US$ 9 billion at newest Indiana site
Largest investment in active pharmaceutical ingredient manufacturing of synthetic medicines in U.S. history
Largest investment in active pharmaceutical ingredient manufacturing of synthetic medicines in U.S. history
The new 10-year contract will focus on strengthening the partnership for continued transformative innovation for patients
Sanofi will leverage this partnership to provide access to proprietary data to develop AI models
EBITDA for the quarter stood at Rs 964 crore, representing an EBITDA margin of 24%
Before joining Gland, Loomba was associated with Shalina Labs, Harman Finochem, Aurobindo Pharma, Sun Pharmaceuticals and Ranabaxy Laboratories.
One form of thalidomide has the intended sedative effect but the opposite mirror-image form interferes with foetal development
The companies also plan to collaborate on several early pipeline projects, further technology exploration, and engineering of scalable manufacturing solutions across Novo Nordisk's portfolio
This partnership combines Tata Elxsi's design and technology expertise along with Dräger's expertise in medical and safety technology
To accelerate the development of next-generation radioconjugates to treat cancer
Subscribe To Our Newsletter & Stay Updated